ARCT logo

ARCT Stock Overview

Profile

Full Name:

Arcturus Therapeutics Holdings Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 22, 2013

Indexes:

Not included

Description:

Arcturus Therapeutics Holdings, Inc. is a pharmaceutical company specializing in the development of drugs for the treatment of liver and respiratory diseases. The company was founded in 2013 with headquarters in San Diego, California. Arcturus Therapeutics is involved in the discovery and development of RNA-based drugs, including the production of RNA drug substance and drug product in nanoparticle form, as well as the development of vaccines against infectious diseases using self-transcribing and replicating RNA (STARR) technology. The company has several preclinical programs, including the LUNAR-OTC program, which is developing mRNA compounds for the treatment of ornithine transcarbamylase (OTC) deficiency, the LUNAR-CF program, which is developing mRNA compounds to replace dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) protein in cystic fibrosis patients, as well as LUNAR-CV and LUNAR-MD programs.

Key Details

Price

$14.75

Annual Revenue

$138.39 M(-12.27% YoY)

Annual EPS

-$3.00(-167.86% YoY)

Annual ROE

-31.16%

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Mar 6, 2025

Recent annual earnings:

Mar 6, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 16, 2017

Analyst ratings

Recent major analysts updates

Mar 7, 25 Wells Fargo
Overweight
Mar 7, 25 HC Wainwright & Co.
Buy
Mar 7, 25 Cantor Fitzgerald
Overweight
Feb 18, 25 HC Wainwright & Co.
Buy
Feb 14, 25 HC Wainwright & Co.
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Jan 7, 25 HC Wainwright & Co.
Buy
Dec 17, 24 HC Wainwright & Co.
Buy
Dec 16, 24 Cantor Fitzgerald
Overweight
Nov 8, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Arcturus Therapeutics Holdings?
  • Does Arcturus Therapeutics Holdings pay dividends?
  • What sector is Arcturus Therapeutics Holdings in?
  • What industry is Arcturus Therapeutics Holdings in?
  • What country is Arcturus Therapeutics Holdings based in?
  • When did Arcturus Therapeutics Holdings go public?
  • Is Arcturus Therapeutics Holdings in the S&P 500?
  • Is Arcturus Therapeutics Holdings in the NASDAQ 100?
  • Is Arcturus Therapeutics Holdings in the Dow Jones?
  • When was Arcturus Therapeutics Holdings's last earnings report?
  • When does Arcturus Therapeutics Holdings report earnings?
  • Should I buy Arcturus Therapeutics Holdings stock now?

What is the ticker symbol for Arcturus Therapeutics Holdings?

The ticker symbol for Arcturus Therapeutics Holdings is NASDAQ:ARCT

Does Arcturus Therapeutics Holdings pay dividends?

No, Arcturus Therapeutics Holdings does not pay dividends

What sector is Arcturus Therapeutics Holdings in?

Arcturus Therapeutics Holdings is in the Healthcare sector

What industry is Arcturus Therapeutics Holdings in?

Arcturus Therapeutics Holdings is in the Biotechnology industry

What country is Arcturus Therapeutics Holdings based in?

Arcturus Therapeutics Holdings is headquartered in United States

When did Arcturus Therapeutics Holdings go public?

Arcturus Therapeutics Holdings's initial public offering (IPO) was on May 22, 2013

Is Arcturus Therapeutics Holdings in the S&P 500?

No, Arcturus Therapeutics Holdings is not included in the S&P 500 index

Is Arcturus Therapeutics Holdings in the NASDAQ 100?

No, Arcturus Therapeutics Holdings is not included in the NASDAQ 100 index

Is Arcturus Therapeutics Holdings in the Dow Jones?

No, Arcturus Therapeutics Holdings is not included in the Dow Jones index

When was Arcturus Therapeutics Holdings's last earnings report?

Arcturus Therapeutics Holdings's most recent earnings report was on Mar 6, 2025

When does Arcturus Therapeutics Holdings report earnings?

The next expected earnings date for Arcturus Therapeutics Holdings is May 8, 2025

Should I buy Arcturus Therapeutics Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions